noscript

News and Announcements

Mesynthes – Investor Presentation Brisbane Capital Showcase

  • Published August 01, 2012 10:57PM UTC
  • Publisher Wholesale Investor
  • Categories CEO Interviews

Mesynthes is a soft-tissue reconstruction company using its proprietary Endoform technology to develop regenerative tissue substitutes for reconstructive surgery and wound care. These markets represent an opportunity in excess of US$1B.


Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now